Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-064369
Filing Date
2009-03-26
Accepted
2009-03-26 16:48:27
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 862481
2 FIRST AMENDMENT TO FIRST AMENDED AND RESTATED LICENSE AGREEMENT dex1012b.htm EX-10.12(B) 24054
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 2007
4 CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9142
5 CERTIFICATION OF THE COMPANY'S CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9147
6 CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 2880
7 CERTIFICATION OF THE COMPANY'S CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 2948
  Complete submission text file 0001193125-09-064369.txt   914281
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-20897 | Film No.: 09707161
SIC: 2834 Pharmaceutical Preparations